News
FEMY
2.350
-0.84%
-0.020
Femasys completes $30 million private placement financing
TipRanks · 1d ago
Weekly Report: what happened at FEMY last week (0803-0807)?
Weekly Report · 3d ago
Femasys Enters $30 Mln Private Placement; Up To $90 Mln Potential Proceeds; Stock Down
NASDAQ · 3d ago
Femasys announces $30M private placement
TipRanks · 5d ago
Femasys Announces $30M Private Placement Led By New Investors And Members Of Management
Benzinga · 5d ago
Press Release: Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Dow Jones · 5d ago
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Barchart · 6d ago
Weekly Report: what happened at FEMY last week (0727-0731)?
Weekly Report · 08/03 09:25
Weekly Report: what happened at FEMY last week (0720-0724)?
Weekly Report · 07/27 09:26
Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filing
NASDAQ · 07/22 03:20
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 07/21 17:05
Weekly Report: what happened at FEMY last week (0713-0717)?
Weekly Report · 07/20 09:25
Weekly Report: what happened at FEMY last week (0706-0710)?
Weekly Report · 07/13 09:25
Weekly Report: what happened at FEMY last week (0629-0703)?
Weekly Report · 07/06 09:27
Weekly Report: what happened at FEMY last week (0622-0626)?
Weekly Report · 06/29 09:25
Femasys Regains Nasdaq Compliance, Focuses On Reproductive Health Pipeline
NASDAQ · 06/25 07:54
Femasys Shareholders Approve Directors and Auditor at Meeting
TipRanks · 06/24 20:34
Femasys Regains Nasdaq Compliance After Reverse Stock Split
TipRanks · 06/24 13:58
Femasys regains Nasdaq listing compliance; shifts focus on growth strategy
Seeking Alpha · 06/24 13:56
Femasys regains compliance with Nasdaq
TipRanks · 06/24 13:15
More
Webull provides a variety of real-time FEMY stock news. You can receive the latest news about FEMASYS INC through multiple platforms. This information may help you make smarter investment decisions.
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.